CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AC4. A total of 21 filers reported holding CLOVIS ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $51,000 | -7.3% | 80,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $55,000 | -77.5% | 80,000 | -75.8% | 0.00% | -83.3% |
| Q1 2022 | $244,000 | +7.0% | 330,000 | 0.0% | 0.01% | +20.0% |
| Q4 2021 | $228,000 | -5.0% | 330,000 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $240,000 | -1.2% | 330,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $243,000 | -2.8% | 330,000 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $250,000 | +8.2% | 330,000 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $231,000 | +0.9% | 330,000 | 0.0% | 0.01% | -14.3% |
| Q3 2020 | $229,000 | +14.5% | 330,000 | 0.0% | 0.01% | +16.7% |
| Q2 2020 | $200,000 | -2.9% | 330,000 | 0.0% | 0.01% | -14.3% |
| Q1 2020 | $206,000 | -1.9% | 330,000 | 0.0% | 0.01% | +16.7% |
| Q4 2019 | $210,000 | +51.1% | 330,000 | 0.0% | 0.01% | +50.0% |
| Q3 2019 | $139,000 | -33.5% | 330,000 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $209,000 | -18.7% | 330,000 | 0.0% | 0.01% | -25.0% |
| Q1 2019 | $257,000 | +10.3% | 330,000 | 0.0% | 0.01% | -11.1% |
| Q4 2018 | $233,000 | -9.3% | 330,000 | 0.0% | 0.01% | +28.6% |
| Q3 2018 | $257,000 | -15.7% | 330,000 | 0.0% | 0.01% | -22.2% |
| Q2 2018 | $305,000 | – | 330,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|